Key Dates

Related Announcements

PAR-18-923 - Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
NOT-AI-20-071 - Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community of the early expiration of  PAR-18-923 "Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)" effective immediately. The January 14, 2021 application due date is no longer available. The Key Dates section of the FOA has been modified to change the Expiration Date from January 15, 2021 to September 10, 2020

Applicants are encouraged to consider applying to NOT-AI-20-071 - Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design.

Inquiries

Please direct all inquiries to:

Cesar Boggiano, PhD
Division of AIDS (DAIDS)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3038
Email:[email protected]

Katrin Eichelberg, PhD
Division of Microbiology and Infectious Diseases (DMID)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2921
Email:[email protected]

Lakshmi Ramachandra, PhD
Division of Allergy, Immunology and Transplantation (DAIT)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-5061
Email:[email protected]